SUBSCRIBE
SUBSCRIBE
News   Drug Development

Breast Cancer Vaccine Tests German Merck KGaA’s $1 Billion Strategy

November 4, 2009 | 
1 min read
Bookmark and Share

Bloomberg -- Merck KGaA of Germany is gambling an unproven therapy that spurs the immune system to attack cancer cells will increase its share of a $48 billion oncology market.
Clinical research Phase II
MORE ON THIS TOPIC
Deals
Inside the 2026 Biotech Landscape: Innovation, Investment and Global Momentum
December 18, 2025
 · 
1 min read
 · 
BioSpace Insights
Weigh scales on pink background, top view with space for text. Overweight concept
Obesity
Lilly’s Obesity Pill Maintains Weight Loss as Estimated Approval Timelines Inch Closer
December 18, 2025
 · 
2 min read
 · 
Tristan Manalac
Halftone collage with hand chart. Growth finance business and marketing. Bright concept with halftone hand. Vector contemporary illustration
Autoimmune disease
Nektar Digs Into Mid-Stage Data to Establish Alopecia Efficacy of Rezpeg
December 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Lilly’s Triple Triumph, Prasad’s COVID Error, J&J’s Surprise Voucher, M&A Targets
December 17, 2025
 · 
2 min read
 · 
Heather McKenzie